Documentos relacionados

1. [Prevalence and frequencies of human papilloma virus types in adenocarcinoma in situ of the uterine cervix].
2. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
3. [Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].
4. A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.
5. Extended human papillomavirus genotype distribution in cervical intraepithelial neoplasia and cancer: Analysis of 40 352 cases from a large academic gynecologic center in China.
6. Expression of PD-L1 through evolution phase from pre-invasive to invasive lung adenocarcinoma.
7. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
8. Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
9. Cervical intraepithelial neoplasia and the risk of spontaneous preterm birth: A Dutch population-based cohort study with 45,259 pregnancy outcomes.
10. Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18.